openPR Logo
Press release

Global Digital Therapeutics Market Revenue and Forecasts to 2025 - Noom, 2Morrow, Livongo Health, Proteus Digital Health, WellDoc, Fitbit

04-17-2019 08:49 AM CET | Health & Medicine

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

In recent years, digital therapeutics market has progressed significantly. The global market for digital therapeutics is anticipated to grow from US$ 1,993.2 Mn in 2017 to US$ 8,941.1 Mn by 2025 at a CAGR of 20.8%.

Rising pressure on healthcare providers to reduce healthcare costs, the rising prevalence of chronic diseases and rising in the number of partnerships and collaborations in the market are the major factors anticipated to propel the growth for the digital therapeutics market. However, the increasing rate of cyber threat and the rise in data security issues is expected to act as major challenges hindering the market growth.

Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application (Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, Others); Distribution Channel (Patients, Providers, Payers, and Employers) and Geography

Get Sample report at https://www.theinsightpartners.com/sample/TIPHC00002236

According to the report of American College of Cardiology Foundation, in 2018, Coronary heart disease (CHD) was the leading cause of deaths attributable to cardiovascular disease (CVD) in the US, which is followed by stroke (16.8%), high BP (9.4%), heart failure (HF) (9.0%), and other CVDs (17.9%). By 2035, approximately 130 million adults in the US population are projected to have some form of CVD. Thus, increasing geriatric population and related chronic diseases are expected to propel the growth of global digital therapeutics market over the forecast years.

Chronic diseases, including heart disease, stroke, diabetes, and obesity, are the leading causes of death in the world and account for most of the nation’s health care costs. According to report of CDC, in 2018, approximately more than 9% of the population has diabetes, which is the leading cause of kidney failure, lower-limb amputations in US. Moreover, the data also suggests that 1.5 million Americans are diagnosed with diabetes every year in the US. Similar trends for high presence of diabetes are prevalent around other geographies of the globe that include Asia Pacific, Europe, Middle East and Africa. For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation in 2017, south-east Asia is home to approximately one-fifth (19%) of the total diabetes population worldwide.

Digital therapeutics help in reducing the costs associated with chronic diseases, by helping an individual or an insurance provider to keep a track of one’s health status as well as track it with the help of digital means. As per American Diabetes Association, the estimated costs of diagnosed diabetes have risen to $327 billion in 2017, including $237 billion in direct medical costs and $90 billion in reduced productivity. This cost can be managed efficiently by including digital therapeutics that are offered by providers to help manage diabetes, can help patients get assistance with disease management and overcome the logistical challenges uncovered by the investigators.

Browse Complete Report at https://www.theinsightpartners.com/reports/digital-therapeutics-market

DIGITAL THERAPEUTICS – MARKET SEGMENTATION

By Application
• Diabetes
• Cardiovascular Diseases
• Central Nervous System (CNS) Disease
• Respiratory Diseases
• Smoking Cessation
• Musculoskeletal Diseases
• Other Applications

By Distribution Channel
• Patients
• Providers
• Payers
• Employers

By Geography
• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• UK
• Asia Pacific (APAC)
• China
• India
• Japan
• Middle East & Africa (MEA)
• Saudi Arabia
• South Africa
• UAE
• South America (SAM)
• Brazil

Company Profiles
• Propeller Health
• CANARY HEALTH
• Noom, Inc.
• 2Morrow Inc.
• Livongo Health
• Proteus Digital Health
• WellDoc, Inc.
• Fitbit, Inc.
• Omada Health, Inc.
• MANGO HEALTH

Acquire Complete Study at https://www.theinsightpartners.com/buy/TIPHC00002236

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –

Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Digital Therapeutics Market Revenue and Forecasts to 2025 - Noom, 2Morrow, Livongo Health, Proteus Digital Health, WellDoc, Fitbit here

News-ID: 1706421 • Views:

More Releases from The Insight Partners

Optical Data Storage Devices Market Growth Sparked by Media and Archiving Demands
Optical Data Storage Devices Market Growth Sparked by Media and Archiving Demand …
New York, US - September 10, 2025- A new report published by The Insight Partners, titled "Optical Data Storage Devices Market - Global Analysis and Forecast," reveals that the global market for optical data storage devices is poised for noteworthy growth. The report highlights that the market is being propelled by the substantial need for long-term data archiving, the increasing demand from high-resolution content creators, and ongoing innovations in disc
Offshore Oil and Gas Pipes, Fittings, and Flanges Market Expected to Grow at 6.3% CAGR, Propelled by Elevated Crude Oil Prices
Offshore Oil and Gas Pipes, Fittings, and Flanges Market Expected to Grow at 6.3 …
New York, US - September 10, 2025- The Insight Partners has published a new report, "Offshore Oil and Gas Pipes, Fittings, and Flanges Market - Global Analysis and Forecast," which reveals that the global market for these essential components is set for robust expansion. The report indicates that the market is being propelled by increasing offshore production, high crude oil prices, and the need to reconstruct existing rigs. The market
Dental Parallelometers Market Boosted by Precision Engineering
Dental Parallelometers Market Boosted by Precision Engineering
New York, US - September 10, 2025 - The Insight Partners has published a new Dental Parallelometers Market report forecasting consistent expansion through 2031. This analysis highlights how the convergence of digital dentistry technologies, ergonomic design improvements, and rising dental procedure volumes is propelling the global Dental Parallelometers Market size and driving market competition. Download PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00017813/?utm_source=OpenPR&utm_medium=10813 Factors Accelerating Market Growth: The Dental Parallelometers Market growth is largely fueled by
Data Preparation Tools Market Rises with Digital Innovation
Data Preparation Tools Market Rises with Digital Innovation
New York, US - September 10, 2025 - The Insight Partners has unveiled a comprehensive Data Preparation Tools Market report, highlighting rapid expansion driven by AI automation, cloud-native technologies, and advanced semantic governance solutions. This report provides a detailed Data Preparation Tools Market analysis, emphasizing the increasing Data Preparation Tools Market size and growing market share within the BFSI, healthcare, retail, and IT sectors. The integration of artificial intelligence and cloud

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and